The pre-treatment prevalence and types of sexual dysfunction among patients diagnosed with prostate cancer

Saitz, Theodore R.; Şerefoğlu, Ege Can; Trost, Landon; Thomas, Raju

doi:10.1111/j.2047-2927.2013.00137.x

Cited by 15 publications

(11 citation statements)

References 17 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…These findings indicate that, while sexual problems may be common in this cohort, men who were sexually active prior to prostate cancer treatment and receive prostate cancer treatment experience high rates of sexual problems following treatment. 4 , 6 , 32 These results, involving a large Scandinavian sample, corroborate existing literature in the area involving samples from other cultural backgrounds and are likely an effect of the prostate cancer treatments themselves and/or their adverse side effects, such as fatigue, urinary and bowel problems, and reduced psychological well-being. 12 , 17 , 20 , 32 …”

Section: Discussionsupporting

confidence: 82%

“…Active prostate cancer treatment is often associated with significant adverse physiological and psychological effects, including muscular weakness, hot flushes, reduced urinary and bowel functioning, depression, reduced quality of life, and sexual problems. 4 , 5 , 6 , 7 , 8 , 9 Prostatic cancer treatment usually involves observation (active surveillance), surgery, radiation therapy, hormonal treatment, and chemotherapy. 10 , 11 , 12 …”

Section: Introductionmentioning

confidence: 99%

“… 7 , 8 , 13 , 14 , 15 , 16 These problems include erectile dysfunction (ED), reduced sexual desire, sexual pain, orgasmic problems, and ejaculatory problems. 4 , 13 , 17 , 18 Among these sexual problems, ED is most commonly studied, and while other sexual problems are less studied, they appear to be highly prevalent and bothersome to prostate cancer patients. 4 , 11 , 12 , 13 Despite the high prevalence rates of sexual problems among prostate cancer patients, a relatively limited number of large sample studies of Scandinavian prostate cancer patients, which both focus on sexual outcomes other than ED and differentiate results based on the most common kinds of treatments received, exist.…”

Section: Introductionmentioning

confidence: 99%

“… 4 , 13 , 17 , 18 Among these sexual problems, ED is most commonly studied, and while other sexual problems are less studied, they appear to be highly prevalent and bothersome to prostate cancer patients. 4 , 11 , 12 , 13 Despite the high prevalence rates of sexual problems among prostate cancer patients, a relatively limited number of large sample studies of Scandinavian prostate cancer patients, which both focus on sexual outcomes other than ED and differentiate results based on the most common kinds of treatments received, exist. 5 Such investigations are important for cultural comparisons and comparison of sexual outcomes across common treatment groups.…”

Section: Introductionmentioning

confidence: 99%

See 3 more Smart Citations

Scandinavian Prostate Cancer Patients’ Sexual Problems and Satisfaction With Their Sex Life Following Anti-Cancer Treatment

et al. 2018

View full text Add to dashboard Cite

IntroductionActive prostate cancer treatment is often associated with significant adverse physiological and psychological effects including significant sexual problems. Most studied among these sexual problems is erectile dysfunction while related sexual bothers such as overall sexual function and satisfaction with one’s sex life are much less studied.AimTo investigate problems related to erectile functioning, orgasmic ability, sexual function, and satisfaction with one’s sex life among a cohort of Scandinavian prostate cancer patients age 40 years and older who were sexually active prior to their diagnosis of prostatic cancer.MethodsThe survey study used a cross-sectional design and a mixed recruitment procedure. Patients were recruited through the prostate cancer patient advocate organizations in Denmark, Norway, and Sweden (Scandinavia). The final sample included 1,707 prostate cancer patients. For analyses, participants were stratified into 4 groups according to their total treatment burden.OutcomesOutcomes included subjective reporting of erectile functioning, orgasm, and sexual functioning, and satisfaction with one's sex life.ResultsThe study found that the prevalence of erectile dysfunction and problems related to orgasm and overall sexual function ranged from 72–92% across prostatic cancer treatment groups. Conversely, this range was 61–69% among the respondents who had not undergone prostatic cancer treatment. Across treatment groups, a minority of patients (<15%) reported being satisfied with their sex lives. After socio-demographic variables were controlled for, patients who did not receive prostatic cancer treatment were 3.75 times more likely than those in the reference group to not report sexual function problems.ConclusionAmong older prostate cancer patients, who at their time of diagnose were sexually active, sexual satisfaction is low and prevalence rates of sexual problems is high, thus underlining the strong clinical need to address sexual problems and satisfaction among this cohort of patients in order to promote sexual health and well-being following active cancer treatments.Martin Hald G, Dahl Pind M, Borre M, et al. Scandinavian Prostate Cancer Patients’ Sexual Problems and Satisfaction With Their Sex Life Following Anti-Cancer Treatment. Sex Med 2018;6:210–216.

show abstract

Section: Discussionsupporting

confidence: 82%

Section: Introductionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

See 2 more Smart Citations

Scandinavian Prostate Cancer Patients’ Sexual Problems and Satisfaction With Their Sex Life Following Anti-Cancer Treatment

et al. 2018

View full text Add to dashboard Cite

show abstract

“…Previous studies are primarily retrospective case-control studies, raising concerns about recall bias, especially given that erectile dysfunction, ejaculatory dysfunction, and decreased libido are common consequences of both PCa and its treatment [31,32]. Moreover, few previous studies have considered ejaculation frequency per se, with most utilizing proxies of sexual activity, such as age at first marriage, marital status, number of sexual partners, and number of children.…”

Section: Discussionmentioning

confidence: 99%

Ejaculation Frequency and Risk of Prostate Cancer: Updated Results with an Additional Decade of Follow-up

et al. 2016

View full text Add to dashboard Cite

Background Evidence suggests that ejaculation frequency may be inversely related to the risk of prostate cancer (PCa), a disease for which few modifiable risk factors have been identified. Objective To incorporate an additional 10 yr of follow-up into an original analysis and to comprehensively evaluate the association between ejaculation frequency and PCa, accounting for screening, clinically relevant disease subgroups, and the impact of mortality from other causes. Design, setting, and participants A prospective cohort study of participants in the Health Professionals Follow-up Study utilizing self-reported data on average monthly ejaculation frequency. The study includes 31 925 men who answered questions on ejaculation frequency on a 1992 questionnaire and followed through to 2010. The average monthly ejaculation frequency was assessed at three time points: age 20–29 yr, age 40–49 yr, and the year before questionnaire distribution. Outcome measurements and statistical analysis Incidence of total PCa and clinically relevant disease subgroups. Cox models were used to estimate hazard ratios (HRs) and 95% confidence intervals (CIs). Results and limitations During 480 831 person-years, 3839 men were diagnosed with PCa. Ejaculation frequency at age 40–49 yr was positively associated with age-standardized body mass index, physical activity, divorce, history of sexually transmitted infections, and consumption of total calories and alcohol. Prostate-specific antigen (PSA) test utilization by 2008, number of PSA tests, and frequency of prostate biopsy were similar across frequency categories. In multivariable analyses, the hazard ratio for PCa incidence for ≥21 compared to 4–7 ejaculations per month was 0.81 (95% confidence interval [CI] 0.72–0.92; p < 0.0001 for trend) for frequency at age 20–29 yr and 0.78 (95% CI 0.69–0.89; p < 0.0001 for trend) for frequency at age 40–49 yr. Associations were driven by low-risk disease, were similar when restricted to a PSA-screened cohort, and were unlikely to be explained by competing causes of death. Conclusions These findings provide additional evidence of a beneficial role of more frequent ejaculation throughout adult life in the etiology of PCa, particularly for low-risk disease. Patient summary We evaluated whether ejaculation frequency throughout adulthood is related to prostate cancer risk in a large US-based study. We found that men reporting higher compared to lower ejaculatory frequency in adulthood were less likely to be subsequently diagnosed with prostate cancer.

show abstract

Sexual dysfunction and prostate cancer therapy

Ridout¹,

Emberton²,

Moore³

2016

Male Sexual Dysfunction

View full text Add to dashboard Cite

The pre-treatment prevalence and types of sexual dysfunction among patients diagnosed with prostate cancer

Cited by 15 publications

References 17 publications

Scandinavian Prostate Cancer Patients’ Sexual Problems and Satisfaction With Their Sex Life Following Anti-Cancer Treatment

Scandinavian Prostate Cancer Patients’ Sexual Problems and Satisfaction With Their Sex Life Following Anti-Cancer Treatment

Ejaculation Frequency and Risk of Prostate Cancer: Updated Results with an Additional Decade of Follow-up

Sexual dysfunction and prostate cancer therapy

Contact Info

Product

Resources

About